Corporate Capital Direct, LLC, a commercial finance firm, announced the national roll out of its medical funding program, Rx Fund Assist.
Rx Fund Assist, historically a regional proprietary funding platform, announces two new additions to its executive board, helping transform the division into a nationally recognized, critical issue solution service for independent pharmacy owners.
Recognizing the challenges facing the retail pharmacy industry, CCD has aligned Rx Fund Assist financial expertise with Jason Melachrino PharmD, MBA, CPh and Jonathan Mordis PharmD, CPh; two expert pharmacists with exceptional track records in building, running and selling pharmacies.
Rx Fund Assist interfaces directly with pharmacy owners searching for capital to assist with daily operations or who are looking to expand.
“Over the last 20 years I have witnessed firsthand the financial stresses related to reimbursement issues, capital demands related to rapid growth trajectory and unmanageable supplier credit situations, and by applying this knowledge individually to each of our clients allows us to search and offer the most effective finance tools and terms for independent pharmacies,” said Mordis.
Melachrino, PharmD, MBA, CPh, Partner VP of Pharmacy has over 20 years of intimate knowledge in a variety of settings in the pharmacy field; through consulting, compounding, retail, administrative and business development.
“In today’s rapidly changing pharmacy landscape, it is more common than ever to fall into cash-flow traps,” he said Melachrino. “We’ll not only help pharmacists negotiate this landscape but also avoid future predicaments through our interdisciplinary, consultative approach.”